ℹ️
🇬🇧
Search
Search for publications relevant for "Clostridioides difficile infection"
Clostridioides difficile infection
Publication
Class
Person
Publication
Programmes
publication
Update on Microbiota-derived therapies for recurrent Clostridioides difficile infections, 2023
2024 |
Second Faculty of Medicine
publication
Updated Czech guidelines for the treatment of clostridioides difficile infection
2022 |
Second Faculty of Medicine, Third Faculty of Medicine
publication
Mortality following clostridioides difficile infection in Europe: A retrospective multicenter case-control study
2021 |
Second Faculty of Medicine
publication
Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?
2022 |
Second Faculty of Medicine
publication
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
2021 |
Publication without faculty affiliation
publication
How to: Clostridioides difficile infection in children
2022 |
Publication without faculty affiliation
publication
Hear My Voice: involving patients in Clostridioides difficile infection research
2023 |
Second Faculty of Medicine
publication
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
2023 |
Second Faculty of Medicine
publication
Clostridioides difficile infection in children hospitalised in Motol University Hospital
2022 |
Second Faculty of Medicine
publication
Re: 'the effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al
2024 |
Second Faculty of Medicine
publication
Effect of Restriction of Fluoroquinolone Antibiotics on Clostridioides difficile Infections in the University Hospital Hradec Králové
2021 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Strong Antimicrobial Effects of Xanthohumol and Beta-Acids from Hops against Clostridioides difficile Infection In Vivo
+1
2021 |
Faculty of Medicine in Hradec Králové
publication
Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection-an observational cohort study
2021 |
Second Faculty of Medicine, Third Faculty of Medicine
publication
Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018-2019
2023 |
Second Faculty of Medicine
publication
An Outbreak of Clostridium (Clostridioides) difficile Infections within an Acute and Long-Term Care Wards Due to Moxifloxacin-Resistant PCR Ribotype 176 Genotyped as PCR Ribotype 027 by a Commercial Assay
2020 |
Second Faculty of Medicine
publication
Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members
2024 |
Second Faculty of Medicine
publication
Clostridium difficile and current views on the treatment and prevention
2020 |
Faculty of Medicine in Hradec Králové
publication
Current use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT
2023 |
Publication without faculty affiliation
publication
The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients
2020 |
Second Faculty of Medicine
publication
2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients
2019 |
First Faculty of Medicine
publication
Faecal microbiota transplantation - secret therapeutic procedure or gut microbiota modulation strategy baseline?
2021 |
Third Faculty of Medicine
publication
Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review
2022 |
Second Faculty of Medicine
publication
Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
2020 |
Second Faculty of Medicine
publication
Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors
2022 |
Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Mathematics and Physics